Akebia Therapeutics
AKBA
AKBA
114 hedge funds and large institutions have $104M invested in Akebia Therapeutics in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.18% less ownership
Funds ownership: 29.42% → 27.24% (-2.2%)
Holders
114
Holding in Top 10
1
Calls
$2.88M
Puts
$1.97M
Top Buyers
| 1 | +$3.67M | |
| 2 | +$2.46M | |
| 3 | +$1.87M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.45M |
| 5 |
Millennium Management
New York
|
+$1.22M |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$2.94M | |
| 3 | -$2.06M | |
| 4 |
BlackRock
New York
|
-$1.07M |
| 5 |
Morgan Stanley
New York
|
-$1.02M |